Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Mar 14, 2022 10:00 AM - Mar 16, 2022 3:15 PM

(US Eastern Standard Time)

Latin America Regulatory Conference

DIA Your Way! Join us virtually from the comfort of your home/office March 14-16 or watch later at a time that works for you. This event provides access to the materials for a full two months!

Session 2 Follow Up: The Evaluation of National Regulatory Authorities as Tool for Strengthening Regulatory Systems in the Americas

Session Chair(s)

Susan  Zavala Coloma, MS, RPh

Susan Zavala Coloma, MS, RPh

Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products

DIGEMID, Peru

Cammilla  Horta Gomes, MA, MPharm

Cammilla Horta Gomes, MA, MPharm

Latam Regulatory Policy Lead

Roche, Brazil

For more than a decade, the Pan American Health Organization (PAHO) has been implementing a regional system for evaluation of National Regulatory Authorities (NRAs) for medicines. This process of evaluation and assessment of NRAs is based on verification of the indicators included in a regionally developed data collection tool, which was based on recommendations from the World Health Organization (WHO). This system has been used to define NRAs of regional reference in the Americas – currently ANMAT, ANVISA, CECMED, COFEPRIS, Health Canada, INVIMA, ISP, and US FDA. The regional data collection tool was the main source used by WHO to create its Global Benchmarking Tool (GBT). This short session aims at providing insights, from PAHO’s perspective, on the future of the assessment of NRAs in the Americas, and how the concept of NRA of regional reference will dialogue with the framework for designating and publicly listing WHO-listed authority (WLA).

Learning Objective : At the conclusion of this session, participants should be able to:
  • Distinguish the concepts of NRAs of regional reference and of WHO Listed Authorities
  • Assess the relevance and purpose of the designation of reference authorities, including in the implementation of reliance
  • Identify the roles and responsibilities of reference authorities in the context of the ongoing efforts in strengthening regulatory systems in the Americas

Speaker(s)

Susan  Zavala Coloma, MS, RPh

Speaker

Susan Zavala Coloma, MS, RPh

DIGEMID, Peru

Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products

Cammilla  Horta Gomes, MA, MPharm

Speaker

Cammilla Horta Gomes, MA, MPharm

Roche, Brazil

Latam Regulatory Policy Lead

Analia  Porras

Interviewee

Analia Porras

Pan American Health Organization (PAHO), United States

Unit Chief, Medicines and Health Technologies

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.